SelectQuote (NYSE:SLQT) Hits New 12-Month Low – Here’s What Happened

SelectQuote, Inc. (NYSE:SLQT – Get Free Report) reached a new 52-week low on Wednesday. The stock traded as low as $5.9001 and last traded at $6.5410, with a volume of 58,061 shares. The stock had previously closed at $6.51.

Analyst Ratings Changes

SLQT has been the subject of several research reports. Zacks Research raised SelectQuote from a “strong sell” rating to a “hold” rating in a research report on Monday, October 26th. Weiss Ratings reissued a “sell (d)” rating on shares of SelectQuote in a research note on Friday. Finally, Wall Street Zen raised SelectQuote to a “hold” rating in a research note on Saturday. One investment analyst has rated the stock with a Strong Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $60.00.

View Our Latest Report on SLQT

SelectQuote Stock Performance

The company has a debt-to-equity ratio of 1.16, a quick ratio of 7.48 and a current ratio of 7.48. The stock’s fifty day moving average price is $8.18 and its 200-day moving average price is $14.38. The company has a market capitalization of $1.16 billion, a P/E ratio of -216.67 and a beta of 2.01.

SelectQuote (NYSE:SLQT – Get Free Report) last issued its quarterly earnings data on Wednesday, November 4th. The company reported ($4.20) earnings per share for the quarter, beating the consensus estimate of ($6.60) by $2.40. The company had revenue of $280.01 million for the quarter, compared to analyst estimates of $277.91 million. SelectQuote had a net margin of 4.61% and a return on equity of 22.48%. As a group, research analysts anticipate that SelectQuote, Inc. will post -0.25 EPS for the current fiscal year.

Insider Transactions at SelectQuote

In other SelectQuote news, CEO Timothy Danker purchased 5,033 shares of the firm’s stock in a transaction dated Friday, November 6th. The shares were bought at an average price of $10.00 per share, for a total transaction of $50,330.00. Following the purchase, the chief executive officer owned 153,803 shares in the company, valued at approximately $1,538,030. This trade represents a 3.38% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Donald L. Hawks III acquired 11,170 shares of the company’s stock in a transaction that occurred on Monday, November 9th. The stock was bought at an average cost of $9.20 per share, with a total value of $102,764.00. Following the purchase, the director owned 38,160 shares in the company, valued at $351,072. The trade was a 41.39% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. In the last 90 days, insiders have acquired 45,993 shares of company stock worth $446,895. 11.60% of the stock is owned by insiders.

Institutional Trading of SelectQuote

Hedge funds have recently modified their holdings of the stock. Cetera Investment Advisers acquired a new position in SelectQuote during the third quarter worth $43,000. Marshall Wace LLP grew its position in shares of SelectQuote by 213.8% in the third quarter. Marshall Wace LLP now owns 866,887 shares of the company’s stock valued at $355,000 after purchasing an additional 590,606 shares in the last quarter. Commonwealth Equity Services LLC increased its holdings in SelectQuote by 541.1% during the 3rd quarter. Commonwealth Equity Services LLC now owns 181,939 shares of the company’s stock worth $74,000 after acquiring an additional 153,562 shares during the period. SMH Capital Advisors Inc. bought a new stake in SelectQuote during the third quarter valued at $47,000. Finally, Fragasso Financial Advisors Inc purchased a new position in shares of SelectQuote during the third quarter worth about $61,000. Institutional investors own 34.59% of the company’s stock.

SelectQuote Company Profile

(Get Free Report)

SelectQuote, Inc. operates a direct-to-consumer insurance distribution platform that helps consumers compare coverage from multiple insurance providers. Its licensed agents assist customers with evaluating options and selecting policies. The company offers Medicare-related products, including Medicare Advantage, Medicare Supplement and prescription drug plans, as well as life, auto and home insurance. Its services also include SelectRx, which provides pharmacy and medication-management services.

Further Reading

Receive News & Ratings for SelectQuote Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SelectQuote and related companies with MarketBeat.com's FREE daily email newsletter.